Thus, the newly found biological activity of sceptrin in inhibiting cell motility, combined with the availability of synthetic sceptrin in multigram quantities, makes sceptrin an interesting candidate for further preclinical studies for treatment of diseases in which inadvertent cell motility is a key contributing factor, such as cancer and chronic inflammation.Here, sceptrin was found to be capab